Omeros to price public offering of stock with a 15%, 30-day greenshoe

Cowen, Wedbush PacGrow assist; deal funds general corporate purposes

By Devika Patel

Knoxville, Tenn., March 13 - Omeros Corp. said it will price a public sale of common stock with a 15%, 30-day greenshoe.

Cowen and Co., LLC is the sole bookrunning manager. Wedbush PacGrow Life Sciences is the co-lead manager.

Proceeds will be used for general corporate purposes, including commercialization of Omidria, research and development, clinical or preclinical activities, capital expenditures and working capital

Omeros is a biopharmaceutical company based in Seattle.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.